What is the prognosis of a ruptured intracranial aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prognosis of Ruptured Intracranial Aneurysm

Ruptured intracranial aneurysms carry a devastating prognosis with 32-67% case fatality and 10-20% of survivors experiencing long-term dependence due to brain damage 1.

Immediate Mortality Risk

The initial hemorrhage severity is the single most powerful predictor of outcome. Approximately 40% of patients die from aneurysmal subarachnoid hemorrhage 2, with the majority of deaths occurring in the acute phase. The risk is highest immediately after rupture, with some studies suggesting up to 15% of patients experience "ultraearly rebleeding" within the first 24 hours 3.

Rebleeding Risk Without Treatment

The natural history of untreated ruptured aneurysms is particularly grim:

  • First 24 hours: 3-4% risk (possibly as high as 15%), with 70% of these occurring within 2 hours of initial rupture 3
  • First 2 weeks: Approximately 20% cumulative risk 1
  • First month: 20-30% cumulative risk, with 1-2% risk per day 3
  • After 3 months: Stabilizes to approximately 3% per year 3

Each subsequent rupture substantially increases mortality and morbidity risk 1. The case fatality rate for rebleeding reaches 70% 3.

Functional Outcomes in Survivors

Among those who survive the initial hemorrhage and receive treatment:

  • 10-20% develop long-term dependence requiring assistance with daily activities 1
  • Many survivors without gross neurological deficits still experience subtle cognitive or neurobehavioral difficulties that impair social adjustment and ability to return to work 3
  • These cognitive deficits appear to result from diffuse effects of subarachnoid hemorrhage rather than focal tissue loss 3

Key Prognostic Factors

Clinical Factors (Strongest Predictors):

Hunt-Hess Grade and Glasgow Coma Scale at presentation are the most critical determinants:

  • Hunt-Hess IV-V: Independent risk factor for mortality 4, 5
  • GCS 9-12: 2.73 times higher risk of poor short-term prognosis 6
  • GCS <9: 3.22 times higher risk of poor short-term prognosis 6

Patient Demographics:

  • Age >60 years: 2.87 times higher risk of poor long-term outcomes 6; ages 65-74 have 1.82× risk, 75-84 have 3.35× risk, and ≥85 have 6.99× risk compared to younger patients 7
  • Male sex: Associated with worse survival 7
  • Blood type O: 1.79 times higher risk of poor outcomes 6

Comorbidities:

  • Hypertension: 1.95 times higher risk of poor long-term outcomes 6
  • Diabetes: 2.04 times higher risk of poor short-term prognosis 6
  • Previous stroke/TIA: Significant independent risk factor 7
  • Chronic kidney disease, end-stage renal disease, congestive heart failure: All associated with worse survival 7

Radiographic Factors:

  • Fisher Grade 3: 1.68 times higher risk of poor outcomes 6
  • Fisher Grade 4: 2.75 times higher risk of poor outcomes 6
  • Multiple ruptured aneurysms: 2.37 times higher risk of poor long-term outcomes 6

Treatment-Related Factors:

  • Postoperative vasospasm: Major predictor of worse outcomes at all time points (discharge, 6 months, 1 year, 5 years, and 10 years) 8
  • Symptomatic cerebral infarction: Independent risk factor for unfavorable outcome 5
  • Conservative (non-interventional) management: 6.89 times higher risk of poor long-term outcomes compared to treatment 6

Treatment Impact on Prognosis

Early treatment within 24-72 hours is critical because the rerupture risk is highest in this period 1. Treatment significantly improves survival compared to conservative management.

Endovascular vs. Surgical Outcomes:

  • Endovascular coiling shows better short-term outcomes with lower perioperative morbidity 9
  • Surgical clipping provides more durable long-term occlusion with lower retreatment rates 9
  • Endovascular treatment was protective in survival analysis (aHR 0.87) compared to surgical clipping 7

Treatment Complications:

For treated patients, combined morbidity and mortality varies by approach:

  • Endovascular: 7.1-9.8% at 1 year depending on prior SAH history 10
  • Surgical: 10.1-12.6% at 1 year depending on prior SAH history 10

Critical Pitfalls

  1. Delayed treatment increases rebleeding risk exponentially - the 1-2% daily risk in the first month means every hour counts 3
  2. Underestimating cognitive deficits - patients with "good" Glasgow Outcome Scale scores may still have significant neurobehavioral impairment affecting quality of life 3
  3. Missing ultraearly rebleeding window - 70% of early rebleeds occur within 2 hours, demanding immediate aneurysm securing 3
  4. Inadequate vasospasm monitoring - this remains the most modifiable predictor of poor outcomes across all time points 8

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.